Alphadyne Asset Management’s Pfizer PFE Stock Holding History

Alphadyne Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$446K	Buy	+18,508	New	+$484K	﹤0.01%	666
2025 Q3	–	Sell	-5,608	Closed	-$138K	–	340
2025 Q2	$136K	Buy	+5,608	New	+$131K	0.02%	147
2023 Q4	–	Sell	-70,692	Closed	-$2.34M	–	143
2023 Q3	$2.34M	Buy	70,692 +55,780	+374%	+$1.97M	0.18%	101
2023 Q2	$547K	Buy	+14,912	New	+$580K	0.07%	81

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Alphadyne Asset Management's PFE Position: Q2 2026 in Review

Alphadyne Asset Management opened a new position in Pfizer (PFE) in Q2 2026: 18,508 shares worth $446K. The stake represents ﹤0.01% of the portfolio and ranks #666 among its holdings. This is a return to the name: Alphadyne Asset Management previously reported a position in PFE as recently as Q2 2025.

Alphadyne Asset Management first reported a position in PFE in Q2 2023 and has held it in 4 quarters since. The position peaked at $2.34M in Q3 2023. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Alphadyne Asset Management held 18,508 shares of Pfizer worth $446K as of Q2 2026.
Pfizer was a new Alphadyne Asset Management position in Q2 2026.
Pfizer made up ﹤0.01% of Alphadyne Asset Management's portfolio in Q2 2026, its #666 holding.
Alphadyne Asset Management first reported a position in Pfizer in Q2 2023 and has held it in 4 quarters since.
Alphadyne Asset Management's Pfizer position peaked at $2.34M in Q3 2023.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Alphadyne Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.